Medical Staff
We pour our hearts into treating every single patient as a VIP.
Board-Certified Dermatologist | Medical Director, Seung-ju Lee
- M.D., Yonsei University College of Medicine
- M.S. in Medicine, Graduate School of Yonsei University College of Medicine
- Dermatology Residency, Gangnam Severance Hospital, Yonsei University Health System
- Board-Certified Dermatologist, Gangnam Severance Hospital, Yonsei University Health System
- Visiting Student, Fudan University (China)
- Visiting Student, Keio University (Japan)
- Clinical Clerkship, Emory University Hospital (USA)
- Former Official Dermatologist & Medical Consultant to the President of South Korea
- Former Chief of Dermatology, Seoul District Hospital, Medical Office of the Office of the President
- Highest Honors Award, Yonsei University College of Medicine
- Best Resident Award, Gangnam Severance Hospital
- Outstanding Resident Research Award, Gangnam Severance Hospital
- Former Medical Director, Irvine Dermatology Clinic
- Best Poster Award, Autumn Meeting of the Korean Dermatological Association
- Best Oral Presentation Award, Spring Meeting of the Korean Dermatological Association
- Best Paper Award, Korean Journal of Dermatology
- Best Poster Award, Korean Society for Investigative Dermatology
- Full Member, Korean Dermatological Association
- Full Member, Association of Korean Dermatologists
- Full Member, Korean Society for Clinical Dermatologic Treatment
- Full Member, Korean Society for Dermatologic Anti-aging
- Full Member, Korean Academy of Aesthetic Dermatology
Publications
1. Distinct signatures of cutaneous microbiome associated with disease severity in Hailey–Hailey disease J Eur Acad Dermatol Venereol 2025;39(3):e266-e268
2. Clinical Course and Long-Term Prognosis of Patients with Recessive Dystrophic Epidermolysis Bullosa in Korea: A Longitudinal, Retrospective Single-Center Study Korean J Dermatol 2022;60(1):7-15
3. Clinical outcome and B-cell kinetics in intercellular immunoglobulin A dermatosis treated with rituximab J Dermatol 2022;49(1):e22-e23
4. Improvement of dysbiosis in patients with atopic dermatitis treated with dupilumab correlates with increased stratum corneum hydration Allergy Asthma Immunol Res 2021;13(4)
5. Invasive Cutaneous Squamous Cell Carcinoma Arising from Chronic Hidradenitis Suppurativa: A Case Report of Treatment by Slow Mohs Micrographic Surgery Ann Dermatol 2021;33(1):68-72
6. Intravenous allogeneic umbilical cord blood–derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients JCI Insight
2021;6(2):e143606
2021;6(2):e143606
7. Childhood granulomatous periorificial dermatitis with extrafacial involvement treated with oral azithromycin and topical pimecrolimus: A case report Korean J Dermatol 2020;58(5)
8. Compound Heterozygous Mutations with a Novel Variant in Integrin Beta4 Cause Epidermolysis Bullosa with Pyloric Atresia and Urologic Abnormalities Yonsei Med J 2020;61(9):831-833
